TriSalus Life Sciences (TLSI) EBIT Growth (3y) (2024 - 2026)
TriSalus Life Sciences (TLSI) EBIT Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 7.13% |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -2.70% |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | 75.54% |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 34.83% |
| 10 | TriSalus Life Sciences | 222.91 Mn | 166.36 Mn | 7.67 Mn | 5.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.98% |
| Dec 31, 2025 | 34.75% |
| Sep 30, 2025 | -3.58% |
| Jun 30, 2025 | -194.08% |
| Mar 31, 2025 | -122.01% |
| Dec 31, 2024 | -87.96% |
| Sep 30, 2024 | -121.22% |
| Jun 30, 2024 | -118.47% |
| Mar 31, 2024 | -235.89% |